Phase II Clinical Development of New Drugs (ICSA Book Series in Statistics)
Overview of phase II clinical development within drug research; insights into statistical methods used in this area. Customer note indicates interest in the topic area
Highlights
- phase II clinical development focus
- statistical methods in drug development
- academic reference in statistics for pharmacology
Pros
- focuses on phase II clinical development
- academic reference for statistics in pharmacology
- contributes to specialized book series on statistics
Cons
- narrow domain may limit broader applicability
- single rating from one customer
- no listed features beyond topic coverage
